[Federal Register Volume 65, Number 62 (Thursday, March 30, 2000)]
[Notices]
[Pages 16962-16963]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 00-7872]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Manufacturer of Controlling Substances; Notice of Registration

    By Notice dated December 16, 1999, and published in the Federal 
Register on December 28, 1999, (64 FR 248), Celgene Corporation, 7 
Powder Horn Drive, Warren, New Jersey 07059, made application by 
renewal to the Drug Enforcement Administration (DEA) to be registered 
as a bulk manufacturer of methylphenidate (1724), a basic class of 
controlled substance listed in Schedule II.
    The firm plans to manufacturer methylphenidate for product research 
and development.
    No comments or objections have been received. DEA has considered 
the

[[Page 16963]]

factors in Title 21, United States Code, Section 823(a) and determined 
that the registration of Celgene Corporation to manufacturer 
methylphenidate is consistent with the public interest at this time, 
DEA has investigated the Celgene Corporation on a regular basis to 
ensure that the company's continued registration is consistent with the 
public interest. These investigations have included inspection and 
testing of the company's physical security systems, audits of the 
company's records, verification of the company's compliance with state 
and local laws, and a review of the company's background and history. 
Therefore, pursuant to 21 U.S.C. 823 and 28 CFR Sec. 0.100 and 0.104, 
the Deputy Assistant Administrator, Office of Diversion Control, hereby 
orders that the application submitted by the above firm for 
registration as a bulk manufacturer of the basic class of controlled 
substance listed above is granted.

    Dated: March 23, 2000.
John H. King,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 00-7872 Filed 3-29-00; 8:45 am]
BILLING CODE 4410 09 M